Proteostasis Therapeutics Inc (PTI)

[Eurotradr]

Proteostasis Therapeutics to Present at the 2020 RBC Capital Markets Global
Healthcare Virtual Conference


BOSTON, May 13, 2020 /PRNewswire/ -- Proteostasis Therapeutics, Inc.
(NASDAQ:PTI), a clinical stage biopharmaceutical company dedicated to the
discovery and development of groundbreaking therapies to treat cystic fibrosis
(CF), today announced that Proteostasis management will present at the 2020
RBC Capital Markets Global Healthcare Virtual Conference on Wednesday, May 20,
2020 at 1:55 p.m. ET.

A live audio webcast of the RBC fireside chat will be available on the
Investor Events page in the Investors & Media section of the Company's
website, www.proteostasis.com. A replay of the webcast will be available on
the Company's website following the presentation.

About Proteostasis Therapeutics, Inc.

Proteostasis Therapeutics, Inc. is a clinical stage biopharmaceutical company
developing small molecule therapeutics to treat cystic fibrosis and other
diseases caused by dysfunctional protein processing. Headquartered in Boston,
MA, the Proteostasis Therapeutics team focuses on identifying therapies that
restore protein function. For more information, visit www.proteostasis.com.